Outcome of lung transplantation for adults with interstitial lung disease associated with genetic disorders of the surfactant system.
Julien BermudezNadia NathanBenjamin CoiffardAntoine RouxSandrine HirschiTristan DegotVincent BunelJérôme Le PavecJulie MaceyAurélie Le BorgneMarie LegendreVincent CottinPascal-Alexandre ThomasRaphael BorieMartine Reynaud-GaubertPublished in: ERJ open research (2023)
Lung transplantation in adults with interstitial lung disease associated with genetic disorders of surfactant system may be a valid therapeutic option. Our data suggest that these patients may have a good prognosis. Immunosuppressive protocol was not changed for these patients, and close lung cancer screening is needed before and after transplantation.
Keyphrases
- interstitial lung disease
- systemic sclerosis
- end stage renal disease
- newly diagnosed
- rheumatoid arthritis
- randomized controlled trial
- prognostic factors
- idiopathic pulmonary fibrosis
- peritoneal dialysis
- extracorporeal membrane oxygenation
- mesenchymal stem cells
- patient reported outcomes
- machine learning
- deep learning
- big data
- artificial intelligence
- cell therapy
- data analysis